Yale University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Yale University sits in the top decile of US sponsors by registered trial count (#13 of 15,742 sponsors by registered trial count).
Yale University: 1,492 sponsored US clinical trials, 254 recruiting.
Yale University sponsors 1,492 registered US clinical trials on ClinicalTrials.gov, 254 of them currently recruiting, and 1,005 completed. 99 of these trials are in Phase 3-4 (later-stage) and 579 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use Disorder, with 19 trials.
Top-decile sponsor footprint
Yale University ranks in the top decile of sponsors by registered trial count (#13 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,005 of 1,138 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,492 total, page 20 of 30
The Lumen Study: Comparing Devices for Patients With Symptomatic Femoro-popliteal Chronic Total Occlusion (CTO)
NCT02145299
Ranolazine and Microvascular Angina by PET in the Emergency Department
NCT02052011
Allocentric Memory in MS and Resting State Functional MRI
NCT02118298
Project Wellness Enhancement: Increasing Health Care Choice and Outcomes for People With Mental Illness
NCT02263742
Care Planning for Older Persons With Multiple Conditions: Encouraging a Tailored Approach (COMET): Stage II
NCT02501967
A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction
NCT02044302
The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users
NCT02102100
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer
NCT02047474
Neuroimmune Response to Lipopolysaccharide
NCT04233593
MK-3475 in Melanoma and NSCLC Patients With Brain Metastases
NCT02085070
Guanfacine Clinical Trial for Smoking Cessation
NCT02051309
Pain Management for Veterans Filing Compensation Claims
NCT02049086
Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma
NCT01974284
STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.
NCT02069925
Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS
NCT02124941
Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma
NCT02007954
Investigating Markers of Energy Metabolism in Pregnant Women With Insulin Resistance
NCT02109094
Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer
NCT02015754
Development of a Nationally Scalable Model of Group Prenatal Care to Improve Birth Outcomes: "Expect With Me"
NCT02169024
AbATE Follow-Up Study
NCT02067923
CHG Dressings in Children With Central Lines
NCT01955226
Evaluation of the Office on Violence Against Women's Domestic Violence Homicide Prevention Demonstrative Initiative
NCT02021838
A Pilot Study of Dietary Chloride Supplementation on Cardiorenal Function in Heart Failure
NCT02031354
CBT for Spanish Speakers
NCT02043210
A Pilot Study Of Riluzole In Patients With Post Traumatic Stress Disorder (PTSD)
NCT02019940
Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer
NCT02057029
A Study to Help People Quit Smoking.
NCT01880099
Randomized Trial of Outpatient vs. Inpatient Management of Low-risk Patients With Upper Gastrointestinal Bleeding.
NCT02005705
Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents
NCT01965184
Progesterone for Smoking Relapse Prevention Following Delivery
NCT01972464
Lifestyle, Exercise and Nutrition Study 2 (LEAN 2)
NCT02110641
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
NCT02005614
Family Based Mindfulness Intervention
NCT01974102
The Gut-brain Axis: a Novel Target for Treating Behavioral Alterations in Obesity
NCT01976156
Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans
NCT02018263
Sequencing CBT for Child Anxiety: CBT Plus Sertraline Versus Switch to Sertraline
NCT01977729
Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy
NCT01945099
Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer
NCT01855828
Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors
NCT02008292
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
NCT01928329
Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance?
NCT01954459
Digestive Endoscopy Suite Radiation Controlling Protective Strategies
NCT02063841
The Role of Emotional Arousal in Food Preference and Taste
NCT02402088
Implementation of HIT-Enhanced Tobacco Treatment for Hospitalized Smokers
NCT01691105
Atypical Lesions of the Breast: Close Observation Versus Excision (ALCOVE)
NCT01925586
Translational Neuroscience Optimization of GlyT1 Inhibitor
NCT01911676
The Effects of Minocycline in Humans
NCT02193269
The Gut-brain Axis in Food Reward and Alcohol Consumption
NCT01902069
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
NCT02313623
Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling
NCT02037035
What is open in the Yale University pipeline
254 recruiting of 1,492 indexed (17% open); 1,005 completed (67%).
Phase mix: 99 late (III/IV) vs 579 early (I/II) (early-phase heavy).
Top condition: Opioid Use Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Yale University: open-pipeline peers nationwide
Peers matched on 1,492 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Yale University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,492 trials (± recruiting share)
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- NYU Langone Health · 17% recruiting · 1,164 trials
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
Related
What to do with this Yale University page
1,492 registered trials is a research-attention snapshot, not an endorsement of Yale University or any single study.
- 254 of Yale University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use Disorder is the condition Yale University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Yale University pipeline card: 1,492 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.